Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Tarsus Pharmaceuticals, Inc.

71.37
-1.4400-1.98%
Volume:316.30K
Turnover:22.83M
Market Cap:3.13B
PE:-65.94
High:74.00
Open:72.55
Low:71.13
Close:72.81
52wk High:85.25
52wk Low:48.20
Shares:43.88M
Float Shares:32.68M
Volume Ratio:0.59
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0824
EPS(LYR):-1.5900
ROE:-13.68%
ROA:-5.48%
PB:9.03
PE(LYR):-44.89

Loading ...

OverviewCompanyNewsFilings

Stock Track | Tarsus Pharmaceuticals Soars 5.61% on Strong XDEMVY Sales Growth and Revenue Beat

Stock Track
·
Feb 24

Tarsus Pharmaceuticals Q4 EPS $(0.20) Misses $(0.11) Estimate, Sales $151.668M Beat $144.565M Estimate

Benzinga Earnings
·
Feb 24

BRIEF-Tarsus Pharmaceuticals Q4 EPS USD -0.2

Reuters
·
Feb 24

Tarsus posts FY 2025 XDEMVY net product sales of USD 451.4 million, up more than 150% YoY

Reuters
·
Feb 24

Tarsus Pharmaceuticals Inc - Phase 2 Study of Tp-05 for Lyme Disease in Q2 2026

THOMSON REUTERS
·
Feb 24

Tarsus Pharmaceuticals Inc - Xdemvy Expected Peak Sales Potential Over $2 Bln

THOMSON REUTERS
·
Feb 24

Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements

GlobeNewswire
·
Feb 24

Analysts’ Top Healthcare Picks: Telix Pharmaceuticals (TLPPF), Tarsus Pharmaceuticals (TARS)

TIPRANKS
·
Feb 22

Tarsus Pharmaceuticals Files Initial Beneficial Ownership Statement for Director David E.I. Pyott

Reuters
·
Feb 21

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Pre-MKt
Financial Report Announcement
May 06, 2026 Post-Mkt
Financial Report Announcement
Feb 23, 2026 Post-Mkt
Financial Report Announcement
Nov 04, 2025 Post-Mkt
Financial Report Announcement
Aug 06, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-65.94
Current
-23.45
Sector Average
4.46%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-65.94
Maximum
-4.68
+1 STD
0.42
Minimum
-120.17
-1 STD
-47.32
Average
-23.45

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.